Voyager Therapeutics (VYGR) Competitors $5.28 +0.55 (+11.63%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$5.35 +0.07 (+1.33%) As of 10/8/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VYGR vs. NBTX, PRAX, COLL, PHAR, UPB, SPRY, RAPP, SYRE, SANA, and BCAXShould you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Nanobiotix (NBTX), Praxis Precision Medicines (PRAX), Collegium Pharmaceutical (COLL), Pharming Group (PHAR), Upstream Bio (UPB), ARS Pharmaceuticals (SPRY), Rapport Therapeutics (RAPP), Spyre Therapeutics (SYRE), Sana Biotechnology (SANA), and Bicara Therapeutics (BCAX). These companies are all part of the "pharmaceutical products" industry. Voyager Therapeutics vs. Its Competitors Nanobiotix Praxis Precision Medicines Collegium Pharmaceutical Pharming Group Upstream Bio ARS Pharmaceuticals Rapport Therapeutics Spyre Therapeutics Sana Biotechnology Bicara Therapeutics Nanobiotix (NASDAQ:NBTX) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability. Does the media prefer NBTX or VYGR? In the previous week, Nanobiotix had 10 more articles in the media than Voyager Therapeutics. MarketBeat recorded 14 mentions for Nanobiotix and 4 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.89 beat Nanobiotix's score of 0.68 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nanobiotix 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Voyager Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate NBTX or VYGR? Nanobiotix currently has a consensus target price of $11.00, suggesting a potential downside of 59.71%. Voyager Therapeutics has a consensus target price of $13.25, suggesting a potential upside of 150.89%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Voyager Therapeutics is more favorable than Nanobiotix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanobiotix 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Voyager Therapeutics 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.89 Which has better valuation and earnings, NBTX or VYGR? Voyager Therapeutics has higher revenue and earnings than Nanobiotix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanobiotix$39.18M33.40-$73.73MN/AN/AVoyager Therapeutics$80M3.66-$65M-$1.85-2.85 Which has more volatility and risk, NBTX or VYGR? Nanobiotix has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Do institutionals & insiders have more ownership in NBTX or VYGR? 38.8% of Nanobiotix shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 3.5% of Nanobiotix shares are held by company insiders. Comparatively, 6.4% of Voyager Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is NBTX or VYGR more profitable? Nanobiotix has a net margin of 0.00% compared to Voyager Therapeutics' net margin of -253.49%. Nanobiotix's return on equity of 0.00% beat Voyager Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets NanobiotixN/A N/A N/A Voyager Therapeutics -253.49%-37.65%-28.89% SummaryVoyager Therapeutics beats Nanobiotix on 10 of the 15 factors compared between the two stocks. Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VYGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VYGR vs. The Competition Export to ExcelMetricVoyager TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$262.37M$3.35B$6.10B$10.55BDividend YieldN/A2.28%5.69%4.75%P/E Ratio-2.8521.5785.4727.60Price / Sales3.66427.64582.22224.03Price / CashN/A47.1237.9261.55Price / Book0.9610.1413.136.76Net Income-$65M-$52.31M$3.30B$275.88M7 Day Performance11.86%5.14%4.29%2.81%1 Month Performance31.67%14.68%9.45%9.24%1 Year Performance-21.89%30.98%86.64%35.42% Voyager Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VYGRVoyager Therapeutics4.1295 of 5 stars$5.28+11.6%$13.25+150.9%-25.4%$262.37M$80M-2.85100News CoverageAnalyst ForecastHigh Trading VolumeNBTXNanobiotix1.2596 of 5 stars$22.78+11.1%$11.00-51.7%+423.2%$1.09B$39.18M0.00100Analyst ForecastAnalyst RevisionGap UpHigh Trading VolumePRAXPraxis Precision Medicines2.2534 of 5 stars$50.98-6.3%$85.56+67.8%-16.2%$1.07B$8.55M-4.15110Analyst ForecastCOLLCollegium Pharmaceutical4.1476 of 5 stars$33.83-2.3%$42.33+25.1%-12.9%$1.07B$631.45M32.53210News CoveragePositive NewsAnalyst ForecastPHARPharming Group2.3135 of 5 stars$15.38-4.7%$30.00+95.1%+69.5%$1.05B$339.84M-118.31280Analyst ForecastShort Interest ↑UPBUpstream Bio1.8915 of 5 stars$18.97+1.8%$56.50+197.8%N/A$1.02B$2.72M0.0038Analyst ForecastSPRYARS Pharmaceuticals2.9039 of 5 stars$10.27-0.4%$33.17+222.9%-20.0%$1.01B$112.34M-20.9690Analyst ForecastRAPPRapport Therapeutics2.8705 of 5 stars$27.74-2.8%$35.33+27.4%+37.3%$1.01BN/A-11.10N/AAnalyst ForecastGap UpSYRESpyre Therapeutics3.2736 of 5 stars$16.67+4.9%$54.29+225.6%-36.6%$1.01B$890K-4.9073Analyst DowngradeSANASana Biotechnology2.5912 of 5 stars$4.16+5.1%$7.50+80.3%+11.0%$989.29MN/A-3.92380Analyst ForecastBCAXBicara Therapeutics2.3177 of 5 stars$18.03+5.8%$32.25+78.9%-20.2%$983.72MN/A-5.6932News CoverageInsider Trade Related Companies and Tools Related Companies Nanobiotix Alternatives Praxis Precision Medicines Alternatives Collegium Pharmaceutical Alternatives Pharming Group Alternatives Upstream Bio Alternatives ARS Pharmaceuticals Alternatives Rapport Therapeutics Alternatives Spyre Therapeutics Alternatives Sana Biotechnology Alternatives Bicara Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VYGR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
